Dermal Therapy Scalp Relief Serum is a leave-on product designed to improve scalp health.
It moisturises, soothes and provides relief for scalp itchiness associated with dry, irritated scalp. It is formulated with Colloidal Oatmeal for skin-soothing moisturisation, Canadian Willowherb to calm irritation and Menthol for its cooling effect.
Clinically tested to provide relief in minutes & suitable for daily and long term use.
Direction of use:
Apply a few drops of the leave-on serum to the affected areas of the scalp as needed. Massage gently. The hair can be wet or dry when applying the serum to the scalp. For best results, use in conjunction with Dermal Therapy Scalp Relief Shampoo & Conditioner.
Water (Aqua), PEG-7 Glyceryl Cocoate, Colloidal Oatmeal, Glycerin, Polyacrylamide, Menthol, Benzyl Alcohol, Caprylyl Glycol, C13-14 Isoparan, Benzoic acid, Sodium Gluconate, Laureth 7, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Epilobium Angustifolium Flower/Leaf/Stem Extract, Sodium hydroxide, Phenoxyethanol, Sodium Metabisulfite
In a clinical-dermatological controlled study, 20 male and female participants aged 18 and over applied Scalp Relief Serum onto the skin to determine its efficacy in reducing itching, swelling and redness on human skin induced by a histamine solution. This known irritant was applied on the skin at the start of the study (T0min), after which Scalp Relief Serum was applied. The skin’s reaction was then assessed over a 60 minute period: after 5 minutes, 15 minutes, 30 minutes, 45 minutes and 60 minutes time interval.
The reduction of itching was evaluated in a 5-point scale indicated in scores from 0 (no itching) to 4 (very severe itching) and the reduction of redness and swelling was measured in dimensions in millimeter.
A gradual reduction in itching, swelling and redness was observed over the 60 minutes period and an average score of 0 (no itching) was observed at T 60min. Results hence showed that Dermal Therapy Scalp Relief Serum was effective in providing relief to the skin.
The above results are from a study conducted on 20 subjects by Dermatest®GmbH in Germany, an independent testing facility as commissioned and funded by Lacorium Health Australia Pty Ltd.